Zhang Han, Yang Yan-min, Zhu Jun, Tan Hui-qiong, Liu Li-sheng
Department of Emergency and Intensive Care Center, Chinese Academy of Medical Science, Beijing, China.
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Jan;40(1):18-24.
To evaluate the impact of admission heart rate (HR) on 30-day all-cause death and cardiovascular events in Chinese patients with ST-elevation acute myocardial infarction (STEMI).
A total of 7485 Chinese STEMI patients from a global randomized controlled trial (CREATE) database were divided into six groups by admission HR: < 60, 60 - 69, 70 - 79, 80 - 89, 90 - 99 and ≥ 100 bpm. The primary outcome was 30-day all-cause death; the secondary outcomes were the composite of 30-day all-cause death, reinfarction, cardiogenic shock or deadly arrhythmia.
Admission glucose level, proportion of female gender, incidence of anterior myocardial infarction, previous diabetes mellitus, hypertension and Killip level II-IV were significantly higher in patients with admission HR ≥ 90 bpm compared to 60 - 69 bpm group (P < 0.05). The 30-day mortality was lowest (6.3%) in the 60 - 69 bpm group and was 9.6% in HR < 60 bpm group (P < 0.05 vs. 60 - 69 bpm group). In patients with admission HR > 60 bpm, the 30-day mortality increased in proportion to higher admission HR: 8.1% in 70 - 79 bpm, 9.2% in 80 - 89 bpm, 12.6% in 90 - 99 bpm and 24.6% in ≥ 100 bpm groups (all P < 0.05 vs. 60 - 69 bpm group). The incidence of MACE was similar as that of 30-day mortality: 27.0% in < 60 bpm, 12.5% in 60 - 69 bpm, 13.7% in 70 - 79 bpm, 14.3% in 80 - 89 bpm, 17.5% in 90 - 99 bpm and 31.1% in ≥ 100 bpm groups. Multivariate analysis showed that the incidence of 30-day mortality positively correlated with the admission HR (P < 0.05) except in the patients with admission HR < 60 bpm (OR = 0.832, P = 0.299), the risk of joint endpoint events was higher in the patients with HR < 60 bpm (OR = 1.532, 95%CI: 1.201 - 1.954, P < 0.05), 90 - 99 bpm (OR = 1.436, 95%CI: 1.091 - 1.889, P < 0.05) or ≥ 100 bpm (OR = 1.893, 95%CI: 1.471 - 2.436, P < 0.001).
Admission HR is an independent risk factor for short-term outcome in Chinese STEMI patients.
评估入院心率(HR)对中国ST段抬高型急性心肌梗死(STEMI)患者30天全因死亡及心血管事件的影响。
来自一项全球随机对照试验(CREATE)数据库的7485例中国STEMI患者按入院心率分为六组:<60、60 - 69、70 - 79、80 - 89、90 - 99及≥100次/分钟。主要结局为30天全因死亡;次要结局为30天全因死亡、再梗死、心源性休克或致命性心律失常的复合结局。
与60 - 69次/分钟组相比,入院心率≥90次/分钟的患者入院血糖水平、女性比例、前壁心肌梗死发生率、既往糖尿病、高血压及KillipⅡ - Ⅳ级比例显著更高(P<0.05)。60 - 69次/分钟组30天死亡率最低(6.3%),心率<6次/分钟组为9.6%(与60 - 69次/分钟组相比,P<0.05)。入院心率>次/分钟的患者中,30天死亡率随入院心率升高而增加:70 - 79次/分钟组为8.1%,80 - 89次/分钟组为9.2%,90 - 99次/分钟组为12.6%,≥100次/分钟组为24.6%(与60 - 69次/分钟组相比,均P<0.05)。主要不良心血管事件(MACE)发生率与30天死亡率相似:<60次/分钟组为27.0%,60 - 69次/分钟组为12.5%,70 - 79次/分钟组为13.7%,80 -次/分钟组为14.3%,90 - 99次/分钟组为17.5%,≥100次/分钟组为31.1%。多因素分析显示,除入院心率<60次/分钟的患者外(比值比[OR]=0.832,P=0.299),30天死亡率发生率与入院心率呈正相关(P<0.05),心率<60次/分钟(OR=1.532,95%置信区间[CI]:1.201 - 1.954,P<0.05)、90 - 99次/分钟(OR=1.436,95%CI:1.091 - 1.889,P<0.05)或≥100次/分钟(OR=1.893,95%CI:1.471 - 2.436,P<0.001)的患者联合终点事件风险更高。
入院心率是中国STEMI患者短期预后的独立危险因素。